UK markets closed

Oxford BioMedica plc (OXB.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
312.00-3.00 (-0.95%)
At close: 04:45PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 331.60M
Enterprise value 339.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.40
Price/book (mrq)4.48
Enterprise value/revenue 3.79
Enterprise value/EBITDA -819.73

Trading information

Stock price history

Beta (5Y monthly) 1.02
52-week change 3-27.34%
S&P500 52-week change 325.87%
52-week high 3474.00
52-week low 3164.29
50-day moving average 3292.13
200-day moving average 3229.77

Share statistics

Avg vol (3-month) 3261.51k
Avg vol (10-day) 3122.49k
Shares outstanding 5105.27M
Implied shares outstanding 6100.01M
Float 866.69M
% held by insiders 120.47%
% held by institutions 155.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 330 May 2018

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -175.89%
Operating margin (ttm)-74.78%

Management effectiveness

Return on assets (ttm)-15.08%
Return on equity (ttm)-117.29%

Income statement

Revenue (ttm)89.54M
Revenue per share (ttm)0.93
Quarterly revenue growth (yoy)-38.80%
Gross profit (ttm)N/A
EBITDA -70.09M
Net income avi to common (ttm)-157.49M
Diluted EPS (ttm)-1.63
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)103.72M
Total cash per share (mrq)1.07
Total debt (mrq)111.46M
Total debt/equity (mrq)143.20%
Current ratio (mrq)3.19
Book value per share (mrq)0.76

Cash flow statement

Operating cash flow (ttm)-28.52M
Levered free cash flow (ttm)-17.12M